These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22983507)

  • 1. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI).
    Koopmans W; Woon ST; Brooks AE; Dunbar PR; Browett P; Ameratunga R
    J Clin Immunol; 2013 Jan; 33(1):68-73. PubMed ID: 22983507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
    Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
    J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
    Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
    J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).
    Garibyan L; Lobito AA; Siegel RM; Call ME; Wucherpfennig KW; Geha RS
    J Clin Invest; 2007 Jun; 117(6):1550-7. PubMed ID: 17492055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.
    Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C
    J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
    Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TACI mutations and disease susceptibility in patients with common variable immunodeficiency.
    Poodt AE; Driessen GJ; de Klein A; van Dongen JJ; van der Burg M; de Vries E
    Clin Exp Immunol; 2009 Apr; 156(1):35-9. PubMed ID: 19210517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family.
    Lougaris V; Gallizzi R; Vitali M; Baronio M; Salpietro A; Bergbreiter A; Salzer U; Badolato R; Plebani A
    Hum Immunol; 2012 Aug; 73(8):836-9. PubMed ID: 22627058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
    Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of TACI mutations: from hypogammaglobulinemia in infancy to autoimmunity in adulthood.
    Barroeta Seijas AB; Graziani S; Cancrini C; Finocchi A; Ferrari S; Miniero R; Conti F; Zuntini R; Chini L; Chiarello P; Bengala M; Rossi P; Moschese V; Di Matteo G
    Int J Immunopathol Pharmacol; 2012; 25(2):407-14. PubMed ID: 22697072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiency.
    Berglund LJ; Jones GJ; Murali R; Fulcher DA
    J Allergy Clin Immunol; 2006 Apr; 117(4):870-7. PubMed ID: 16630947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.
    Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD
    Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TACI mutation in common variable immunodeficiency and IgA deficiency.
    Rachid R; Castigli E; Geha RS; Bonilla FA
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):357-62. PubMed ID: 16899196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies.
    Speletas M; Mamara A; Papadopoulou-Alataki E; Iordanakis G; Liadaki K; Bardaka F; Kanariou M; Germenis AE
    J Clin Immunol; 2011 Aug; 31(4):550-9. PubMed ID: 21547394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
    Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
    J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8.
    Waldrep ML; Zhuang Y; Schroeder HW
    BMC Med Genet; 2009 Sep; 10():100. PubMed ID: 19775471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TACI, isotype switching, CVID and IgAD.
    Castigli E; Geha RS
    Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological characteristics and two novel mutations in TACI in a cohort of 28 pediatric patients with common variable immunodeficiency.
    Almejún MB; Sajaroff E; Galicchio M; Oleastro M; Bernasconi A; Zelazko M; Danielian S
    J Clin Immunol; 2012 Feb; 32(1):89-97. PubMed ID: 22076597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
    Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
    J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.